Copyright
©The Author(s) 2025.
World J Gastroenterol. May 28, 2025; 31(20): 104038
Published online May 28, 2025. doi: 10.3748/wjg.v31.i20.104038
Published online May 28, 2025. doi: 10.3748/wjg.v31.i20.104038
Figure 4 Treatment process of the patient during the induction therapy.
UC: Ulcerative colitis; ASA: Aminosalicylic acid; SFS: Stool frequency score; RBS: Rectal bleeding score; MES: Mayo endoscopic score; FC: Fecal calprotectin; PG: Pyoderma gangrenosum; SCZ: Schizophrenia; UPA: Upadacitinib; ADA: Adalimumab; SC: Subcutaneous injection; AE: Adverse events.
- Citation: He SD, Tian Y. Upadacitinib for ulcerative colitis and pyoderma gangrenosum in a patient with schizophrenia on long-term risperidone: A case report. World J Gastroenterol 2025; 31(20): 104038
- URL: https://www.wjgnet.com/1007-9327/full/v31/i20/104038.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i20.104038